Problems in histological grading of malignancy and its clinical significance in patients with operable Breast Cancer

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Breast Cancer

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.2325/jbcs.13.249PMID 16929117
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Meeting highlights: international expert consensus on the primary therapy of early breast cancer 2005.

  2005cited by this paper
• Establishment of histological criteria for high-risk node-negative breast carcinoma for a multi-institutional randomized clinical trial of adjuvant therapy. Japan National Surgical Adjuvant Study of Breast Cancer (NSAS-BC) Pathology Section.

  1998cited by this paper
• Prognostic significance of accumulation of gene and chromosome alterations and histological grade in node-negative breast carcinoma.

  1998cited by this paper
• Histologic malignancy grading of invasive ductal breast carcinoma. A regression analysis of prognostic factors in low‐risk carcinomas from a multicenter trial

  1987cited by this paper
• The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy.

  1987cited by this paper
• Histological typing of breast tumors.

  1982cited by this paper
• Regression Models and Life-Tables

  1972cited by this paper
• Histological Grading and Prognosis in Breast Cancer

  1957cited by this paper

• Assessment of Chromosomal Aberrations and S-phase Fraction in Patients With Esophageal Cancer

  2025cites this paper
• Multi-Path Convolutional Architecture with Channel-Wise Attention for Multiclass Brain Tumor Detection in Magnetic Resonance Imaging Scans

  2025cites this paper
• Deep Convolutional Network‐Based Probabilistic Selection Approach for Multiclassification of Brain Tumors Using Magnetic Resonance Imaging

  2025cites this paper
• Advancing Brain Tumor Analysis: Current Trends, Key Challenges, and Perspectives in Deep Learning-Based Brain MRI Tumor Diagnosis

  2025cites this paper
• A Convolutional Block Base Architecture for Multiclass Brain Tumor Detection Using Magnetic Resonance Imaging

  2024cites this paper
• Brain Tumor Detection Based on Deep Learning Approaches and Magnetic Resonance Imaging

  2023cites this paper
• Genomics in Clinical trials for Breast Cancer.

  2023cites this paper
• YoDenBi-NET: YOLO + DenseNet + Bi-LSTM-based hybrid deep learning model for brain tumor classification

  2023cites this paper
• Artificial Intelligence Scheme for Medical Images Classification and Prediction

  2022cites this paper
• Prognosis Prediction Through an Integrated Analysis of Single-Cell and Bulk RNA-Sequencing Data in Triple-Negative Breast Cancer

  2022cites this paper
• Beyond Genetics: Metastasis as an Adaptive Response in Breast Cancer

  2022cites this paper
• 3E-Net: Entropy-Based Elastic Ensemble of Deep Convolutional Neural Networks for Grading of Invasive Breast Carcinoma Histopathological Microscopic Images

  2021cites this paper
• Performance optimisation of deep learning models using majority voting algorithm for brain tumour classification

  2021cites this paper
• Morphological features of single cells enable accurate automated classification of cancer from non-cancer cell lines

  2021cites this paper
• Association of 18F-FDG PET/CT textural features with immunohistochemical characteristics in invasive ductal breast cancer.

  2021cites this paper
• Association of 18F-FDG PET/CT textural features with immunohistochemical characteristics in invasive ductal breast cancer.

  2021cites this paper
• Prognostic Significance of Cellular Iron Metabolism in Breast Cancer

  2021cites this paper
• Image-based Classification of Tumor Type and Growth Rate using Machine Learning: a preclinical study

  2019cites this paper
• Comparative oncology research in Australia: establishing the Australian Veterinary Cancer Biobank to validate canine mammary tumours as a model for human breast cancer

  2018cites this paper
• PET Imaging on Dynamic Metabolic Changes after Combination Therapy of Paclitaxel and the Traditional Chinese Medicine in Breast Cancer-Bearing Mice

  2018cites this paper
• Heterogeneity in untreated, stressed and drug-tolerant cells: insights into the evolution of cancer resistance

  2018cites this paper
• Pre-therapy Somatostatin Receptor-Based Heterogeneity Predicts Overall Survival in Pancreatic Neuroendocrine Tumor Patients Undergoing Peptide Receptor Radionuclide Therapy

  2018cites this paper
• CAENORHABDITIS ELEGANS AS A MODEL TO DETERMINE THE MOLECULAR EFFECTS OF PLAUSIBLE ENVIRONMENTAL RISK FACTORS OF BREAST CANCER

  2017cites this paper
• Grading of invasive breast carcinoma through Grassmannian VLAD encoding

  2017cites this paper
• Chapter 3 Population Genetics of Neoplasms

  2017cites this paper
• Population Genetics of Neoplasms

  2016cites this paper
• Clinical Outcomes and Prognostic Factors of Pathologic N3 Breast Cancer Treated With Modern Standard Treatments.

  2015cites this paper
• Breast Tumor Heterogeneity: Source of Fitness, Hurdle for Therapy.

  2015cites this paper
• The pharmacological point of view of resistance to therapy in tumors.

  2014cites this paper
• Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma

  2014cites this paper
• Second-Generation Sequencing for Cancer Genome Analysis

  2014cites this paper
• Development of a Mathematical Model to Understand, Design & Improve Oncolytic Virus Therapies

  2014cites this paper
• Nuclear pleomorphism: role in grading and prognosis of canine mammary carcinomas.

  2014cites this paper
• A molecular characterization of breast cancer progression, including onset, tumor growth and metastasis

  2014cites this paper
• Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients.

  2013cites this paper
• Dual-Color Fluorescence In Situ Hybridization Reveals an Association of Chromosome 8q22 but Not 8p21 Imbalance with High Grade Invasive Breast Carcinoma

  2013cites this paper
• DNA Ploidy is an Independent Predictor of Survival in Breast Invasive Ductal Carcinoma: A Long-term Multivariate Analysis of 393 Patients

  2013cites this paper
• [DNA ploidy is an independent prognostic biomarker in breast invasive ductal carcinoma].

  2013cites this paper
• Adapting clinical paradigms to the challenges of cancer clonal evolution.

  2013cites this paper
• New Developments in Breast Cancer Prognosis: Molecular Predictors of Treatment Response and Survival

  2013cites this paper
• Konkordanz von Mutationen von KRAS und BRAF in Primärtumor und korrespondierender Metastase des kolorektalen Karzinoms

  2013cites this paper
• CDK12 IS A NOVEL ONCOGENE WITH CLINICAL AND PATHOGENETIC RELEVANCE IN BREAST CANCER

  2013cites this paper
• A Ploidia de ADN é um Biomarcador Prognóstico Independente no Carcinoma Ductal Invasivo da Mama

  2013cites this paper
• The presence of alveolar structures in invasive ductal NOS breast carcinoma is associated with lymph node metastasis

  2013cites this paper
• Comparison of the prognostic value of genomic grade index, Ki67 expression and mitotic activity index in early node-positive breast cancer patients

  2013cites this paper
• Intra-tumour heterogeneity: a looking glass for cancer?

  2012cites this paper
• The Embryonic Protein Nodal Supports Metastatic Phenotypes in Breast Cancer

  2012cites this paper
• Evolution of the cancer genome.

  2012cites this paper
• The Use of Immunohistochemistry for Biomarker Assessment—Can It Compete with Other Technologies?

  2011cites this paper
• Insight into the heterogeneity of breast cancer through next-generation sequencing.

  2011cites this paper
• Cyclin E low-molecular-weight isoform as a predictor of breast cancer in Japanese women.

  2011cites this paper
• Molecular biology of breast cancer

  2010cites this paper
• Strategies to Incorporate Translational Research Science into Clinical Trials in Breast Cancer

  2010cites this paper
• Tracing the tumor lineage

  2010cites this paper
• Inferring tumor progression from genomic heterogeneity.

  2010cites this paper
• Bioinformatics study indicates possible microRNA-regulated pathways in the differentiation of breast cancer

  2010cites this paper
• Chapter 25 – Molecular Biology of Breast Cancer

  2009cites this paper
• Molecular Changes in Primary Breast Tumors and the Nottingham Histologic Score

  2009cites this paper
• Genomic Heterogeneity of Breast Tumor Pathogenesis

  2009cites this paper
• Perinucleolar compartment prevalence is a phenotypic pancancer marker of malignancy

  2008cites this paper
• BLOOM-RICHARDSON GRADING: A MARKER OF CHEMOSENSITIVITY IN INVASIVE BREAST CARCINOMAS

  2008cites this paper
• [Diagnostic techniques in breast cancer detection. Part III. The new cytobiological methods].

  2007cites this paper